Leprosy Test From Protein AI Gets $700K
Luke Timmerman2/20/09
Protein AI, a Seattle-based developer of a diagnostic test for leprosy, has received a $700,000 Small Business Innovation Research grant. The disease is currently detected when a doctor recognizes skin lesions or runs an antibody-based lab test. Protein AI’s test is designed so a pinprick of blood can be collected and provide an answer within 15 minutes, says CEO Darrick Carter. The test should be on the market by the end of 2009 or early 2010, he says.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
